Brazil: One Volunteer Dies In Oxford Corona Vaccine Trial, Won’t Stop Trial

Read Time:2 Minute, 15 Second

A volunteer involved in the corona vaccine trial being developed by AstraZeneca and Oxford University has died. The Brazilian Health Authority Anvisa reported this on Wednesday. However, despite the death of the volunteer, the vaccine trials will not be stopped. No further information has been provided about this due to medical confidentiality.

According to the Federal University of Sao Paulo (which is conducting a trial for the third phase of the Coronavirus vaccine in Brazil), the dying volunteer was from Brazil, but no information has been given about where he lived. AstraZeneca’s shares have fallen by 1.7 percent due to news of volunteer deaths.

More than 154,000 people have lost their lives due to the corona epidemic in Brazil. Brazil is the second most affected country after the U.S. in terms of corona patients’ deaths. Brazil is also the third most infected country in the world in cases of corona infections. In this case, the US and India are ranked the first second respectively.

Worldwide, work is going on to prepare the coronavirus vaccine and medicine. Many experts have expressed hope that the vaccine could be ready within the next two and a half months. In the meantime, however, there are also questions about the corona vaccine and medicine safety. For safety reasons, the trial of a vaccine and an antibody-drug had to be stopped within 24 hours.

The first U.S. company Johnson & Johnson’s coronavirus vaccine trial had to be halted for safety reasons. The trial of the American’s Eli Lilly company’s coronavirus antibody drug was also stopped.

Eli Lilly Company is developing two antibody medications. One name is LY-CoV555 and the other is LY-CoV016. The company has also applied to the FDA for emergency use approval of LY-CoV555. So far, it is not clear which of these antibodies has been stopped the trial.

Eli Lilly’s company has prevented the trial of antibody drugs for “possible safety reasons.” The Independent Safety Monitoring Board had recommended a halt to the trial. However, the company has not revealed how many volunteers who have been vaccinating have seen health problems. However, it has been reported that Eli Lilly’s antibody-drug was being tested on corona patients admitted to the hospital.

Johnson & Johnson decided to halt the trial of its corona vaccine when a volunteer reported a disease. Eli Lilly is the company’s antibody-drug as the drug was treated by US President Donald Trump. Trump was given antibody treatment for the Regeneron company.

Earlier, Oxford University’s corona vaccine trial was also halted for safety reasons, after trials were resumed in other countries, but the US still bans Oxford’s corona vaccine trial.

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleppy
Sleppy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %